ALK and inflammatory myofibroblastic tumor: Additionally, Ouchi et al. identified FN1 as a fusion partner of ALK by 5′RACE, FN1-ALK, resulted in ALK overexpression in the inflammatory myofibroblastic tumors, and this finding should facilitate development of novel therapeutics (Ouchi et al., 2015).